Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recombinant Newcastle disease virus expressing human TRAIL as a potential candidate for hepatoma therapy

Published:2017-05 Issue: Volume:802 Page:85-92
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Wu Yunzhou,He Jinjiao,Geng Jingshu,An Ying,Ye Xianlong,Yan Shijun,Yu Qingzhong,Yin Jiechao,Zhang Zhenyu,Li Deshan

Funder

National Natural Science Foundation of China

Heilongjiang Funds for Young Scientists

Department for Heilongjiang Education Fund

Department for Harbin Science and Technology Funds for Young Scientists

Young Talents Project of Northeast Agricultural University

Publisher

Elsevier BV

Subject

Pharmacology

Reference42 articles.

1. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J. Clin. Invest.,1999

2. 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire;Batliwalla;Mol. Med,1998

3. Oncolytic viruses: programmable tumour hunters;Bell;Curr. Gene Ther.,2002

4. Atypical disease produced in chickens by Newcastle disease virus isolated from exotic birds;Brugh;Avian. Dis.,1984

5. Csatary, L.K.,1971. Viruses in the Treatment of Cancer. Lancet. 2, p. 825.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting;International Immunopharmacology;2024-07

2. Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein;Veterinary Research;2024-02-05

3. Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer;Journal of Translational Medicine;2024-01-02

4. Interleukin-2 and Oncolytic Virotherapy: A New Perspective in Cancer Therapy;Anti-Cancer Agents in Medicinal Chemistry;2023-11

5. Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches;Pharmaceutics;2022-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3